fianlimab,cemiplimab
sanofi,regeneron
['fianlimab', 'cemiplimab', 'melanoma']
promising significant durable response w/fianlimab + cemiplimab in advanced melanoma presented by at #asco23. drawing on this, et al highlight initial safety &amp; efficacy data w/lag-3 + anti-pd-1 combo in this popular #jitc article: 
The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Interim Editor-in-Chief: James L. Gulley (@gulley1)